Results for the First Quarter 2017

Sales in the first quarter amounted to MNOK 74.4 (MNOK 65.5), a 13.5 % growth. Currency neutral growth of own products was 20.3 %. Sales from the US increases with 9.6 % in USD. In…

Read more

Annual Report 2016

Sales for the group in 2016 ended at 268.1 MNOK (251.4 MNOK), a 6.6 % growth. Download full report here: Annual Report Medistim 2016

Read more

Results for the Fourth Quarter 2016

Currency neutral sales of own products decreased with 3 MNOK or 5.7 % due in part to a back order situation on TTFM flow probes. Currency neutral sales of own products increased with 9.5 %…

Read more

Medistim Establishes Own Subsidiary in Spain

Annually, around 7.000 coronary artery bypass surgery (CABG) procedures and 8.000 vascular procedures are performed throughout the 56 cardiac centers and 75 vascular centers in Spain. Medistim currently has an installed base of 80 systems,…

Read more

Medistim introduces the SonoQ™ to the Indian market

Medistim launches the SonoQ™ at the ICC congress in New Delhi, India 11-13 November 2016 “Medistim is the market leader with high-end products for surgical guidance and blood flow measurement in cardiac-, vascular and transplant surgery…

Read more

Results for the Third Quarter 2016

Sales in the 3rd quarter ended at MNOK 67.9 (MNOK 61.6), a 10.2 % increase. USA had a strong quarter with an 18.5% growth in sales. In Asia sales increased with 83.6 % while in…

Read more

Results for the Second Quarter 2016

Europe had a strong quarter with a 20.3% growth in sales, while sales in the US increased by 10.9%. Sales in Asia increased by 40.4% and there was a sales growth of 5.7 % in…

Read more

Results for the First Quarter 2016

Sales for the quarter ended at MNOK 65.5 which is a 13.1 % sales growth for the quarter. Sales of own products increased with 28.8 % to MNOK 49.1 and US sales up 42.8 %…

Read more